Inspira Technologies OXY B.H.N. Ltd 6-K Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

,

Filing date:

03/14/2025


TLDR:

Inspira Technologies entered into a sales agreement with A.G.P./Alliance Global Partners to offer and sell ordinary shares up to $1,019,000 for general corporate purposes.

ELI5:

Inspira Technologies is partnering with A.G.P./Alliance Global Partners to sell up to $1,019,000 worth of its shares. The money raised will be used to fund the company’s research, marketing, and overall business growth.


Accession #:

0001213900-25-024178

Published on

Analyst Summary

  • Inspira Technologies Oxy B.H.N. Ltd. has entered into a Sales Agreement with A.G.P./Alliance Global Partners to sell ordinary shares with an aggregate offering price of up to $1,019,000.
  • The Ordinary Shares will be offered and sold pursuant to the Registrant’s Registration Statement on Form F-3 (File No. 333-266748) and the related base prospectus included in the Registration Statement, as supplemented by the prospectus supplement to the Registration Statement dated March 14, 2025.
  • The company expects to use the proceeds from the sale of Ordinary Shares for general corporate purposes, including financing research and development, business development marketing activities and implementation of the company’s commercialization strategy.
  • The Registrant is not obligated to sell any Ordinary Shares under the Sales Agreement.
  • The Sales Agent will use commercially reasonable efforts to sell Ordinary Shares from time to time based upon the Registrant’s instructions, including any price, time or size limits specified by the Registrant.
  • The Registrant will pay the Sales Agent a commission equal to 3.0% of the aggregate gross proceeds from each sale of Ordinary Shares and has agreed to provide the Sales Agent with customary indemnification and contribution rights.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️